Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients
Status:
Recruiting
Trial end date:
2021-09-10
Target enrollment:
Participant gender:
Summary
Safety and Efficacy of Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac
(PBOHB) ophthalmic compound compared to Pilocarpine and Brimonidine to improve uncorrected
near vision in healthy presbyopic patients one hour after instillation.